2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation, cilt.143, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 143
- Basım Tarihi: 2021
- Doi Numarası: 10.1161/cir.0000000000000932
- Dergi Adı: Circulation
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, CAB Abstracts, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
- Anahtar Kelimeler: AHA Scientific Statements, anticoagulation therapy, aortic regurgitation, aortic stenosis, bicuspid aortic valve, cardiac surgery, infective endocarditis, mitral regurgitation, mitral stenosis, mitral transcatheter edge-to-edge repair, prosthetic valve, pulmonic regurgitation, pulmonic stenosis, anscatheter aortic valve replacement or implantation, tricuspid regurgitation, tricuspid stenosis, valvular heart disease, AORTIC-VALVE-REPLACEMENT, ISCHEMIC MITRAL REGURGITATION, LONG-TERM OUTCOMES, LEFT-VENTRICULAR FUNCTION, CORONARY-ARTERY-DISEASE, FUNCTIONAL TRICUSPID REGURGITATION, DIRECT ORAL ANTICOAGULANTS, INTRAOPERATIVE TRANSESOPHAGEAL ECHOCARDIOGRAPHY, STAPHYLOCOCCUS-AUREUS ENDOCARDITIS, CARDIAC RESYNCHRONIZATION THERAPY
- Eskişehir Osmangazi Üniversitesi Adresli: Evet
Özet
AIM: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use.